Innoviva
INVA
194 hedge funds and large institutions have $884M invested in Innoviva in 2020 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 60 increasing their positions, 71 reducing their positions, and 30 closing their positions.
25% more call options, than puts
Call options by funds: $36.2M | Put options by funds: $29M
13% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 30
1% more funds holding
Funds holding: 193 → 194 (+1)
0.18% more ownership
Funds ownership: 73.94% → 74.12% (+0.18%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 71
17% less capital invested
Capital invested by funds: $1.06B → $884M (-$176M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$12M |
| 2 |
SG Americas Securities
New York
|
+$7M |
| 3 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$4.58M |
| 4 |
Renaissance Technologies
New York
|
+$4.1M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
+$3.93M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$8.39M |
| 2 |
BlackRock
New York
|
-$4.04M |
| 3 |
Morgan Stanley
New York
|
-$3.92M |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$3.27M |
| 5 |
CEP
Chicago Equity Partners
Chicago,
Illinois
|
-$2.98M |
INVA Hedge Fund Activity: Q1 2020 in Review
194 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q1 2020, worth a combined $884M — down 17% from $1.06B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new INVA positions and 30 closed out — a net gain of 4 holders — while 60 added to existing stakes and 71 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $12M. The largest seller was Invesco, cutting an estimated $8.39M.
- 194 institutional investors held Innoviva (INVA) as of Q1 2020, up from 193 in Q4 2019.
- Funds reported $884M of Innoviva stock for Q1 2020, down 17% quarter-over-quarter.
- 34 funds opened new Innoviva positions in Q1 2020 and 30 closed out, a net change of +4 holders.
- The largest Innoviva buyer in Q1 2020 was Goldman Sachs, an estimated $12M added.
- The largest Innoviva seller in Q1 2020 was Invesco, an estimated $8.39M sold.
Based on aggregated 13F filings for Q1 2020.